Ogoc, Manilyn G.
HRN: 21-50-51 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
CEFUROXIME 1.5GM (VIAL)
06/08/2022
06/09/2022
IV
1.5
Q8
S/p Pelvic Lap
Waiting Final Action
06/08/2022
CEFUROXIME 500MG (TAB)
06/09/2022
06/15/2022
PO
500mg
Q12H
S/p Pelvic Lap
Waiting Final Action